On June 16, 2026, Trinity Biotech PLC announced it received significant orders for more than 2 million TrinScreen HIV tests. The company also released its financial results for the first quarter ended March 31, 2026. Trinity Biotech PLC is a biotechnology company that develops and manufactures diagnostic products.
